-
1 Comment
Afya Limited is currently in a long term uptrend where the price is trading 4.8% above its 200 day moving average.
From a valuation standpoint, the stock is 95.2% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 8.5.
Afya Limited's total revenue rose by 49.7% to $309M since the same quarter in the previous year.
Its net income has increased by 52.8% to $75M since the same quarter in the previous year.
Finally, its free cash flow grew by 117.7% to $91M since the same quarter in the previous year.
Based on the above factors, Afya Limited gets an overall score of 5/5.
| ISIN | KYG011251066 |
|---|---|
| Sector | Consumer Defensive |
| Industry | Education & Training Services |
| Exchange | NASDAQ |
| CurrencyCode | USD |
| Market Cap | 2B |
|---|---|
| PE Ratio | 14.56 |
| Target Price | 19.9751 |
| Dividend Yield | 1.2% |
| Beta | 0.61 |
Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers printed and digital content and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for AFYA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
